These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30808718)
1. Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. Chao CC; Chen PC; Chiou PC; Hsu CJ; Liu PI; Yang YC; Reiter RJ; Yang SF; Tang CH Clin Sci (Lond); 2019 Mar; 133(5):709-722. PubMed ID: 30808718 [TBL] [Abstract][Full Text] [Related]
2. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a. Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326 [TBL] [Abstract][Full Text] [Related]
3. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma. Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909 [TBL] [Abstract][Full Text] [Related]
4. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736 [TBL] [Abstract][Full Text] [Related]
5. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Yu J; Xie F; Bao X; Chen W; Xu Q Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626 [TBL] [Abstract][Full Text] [Related]
6. Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, β-catenin, and Twist pathways. Yang YC; Chiou PC; Chen PC; Liu PY; Huang WC; Chao CC; Tang CH Environ Toxicol; 2019 Feb; 34(2):203-209. PubMed ID: 30421542 [TBL] [Abstract][Full Text] [Related]
7. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779 [TBL] [Abstract][Full Text] [Related]
8. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509 [TBL] [Abstract][Full Text] [Related]
9. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways. Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255 [TBL] [Abstract][Full Text] [Related]
10. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420 [TBL] [Abstract][Full Text] [Related]
11. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer. Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741 [TBL] [Abstract][Full Text] [Related]
12. Involvement of the transcription factor twist in phenotype alteration through epithelial-mesenchymal transition in lung cancer cells. Nakashima H; Hashimoto N; Aoyama D; Kohnoh T; Sakamoto K; Kusunose M; Imaizumi K; Takeyama Y; Sato M; Kawabe T; Hasegawa Y Mol Carcinog; 2012 May; 51(5):400-10. PubMed ID: 21594904 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT. Li R; Wu C; Liang H; Zhao Y; Lin C; Zhang X; Ye C Int J Oncol; 2018 Oct; 53(4):1763-1773. PubMed ID: 30066890 [TBL] [Abstract][Full Text] [Related]
14. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma. Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173 [TBL] [Abstract][Full Text] [Related]
15. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis. Yeeravalli R; Kaushik K; Das A Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139 [TBL] [Abstract][Full Text] [Related]
16. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor. Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
18. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer. Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854 [TBL] [Abstract][Full Text] [Related]
19. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer. Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239 [TBL] [Abstract][Full Text] [Related]
20. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]